Assessment of medical doctors' knowledge of new psychoactive substances and their neurobehavioural effects

Abstract

New Psychoacve Substances (NPS), also known as designer drugs, pose significant public health risks due to their potent psychoacve  properes and potenal neurobehavioural effects. Medical doctors play a crucial role in idenfying and addressing the health risks associated with NPS use. This study assessed medical doctors' knowledge of NPS and their neurobehavioral effects. A cross-seconal  online survey of licensed medical doctors was conducted, revealing varying levels of awareness and knowledge regarding NPS. While respondents showed familiarity with NPS terminology and street names, gaps existed, parcularly concerning specific NPS categories. This  underscores the importance of enhancing medical professionals' understanding of NPS to ensure comprehensive paent care and  informed treatment decisions.